Literature DB >> 10675288

Bilateral 6-OHDA lesions to the hippocampus attenuate the facilitatory effect of CCK-8 us and caerulein on memory in rats.

M M Winnicka1, K Wisniewski.   

Abstract

The involvement of dopaminergic projection to the hippocampus in the facilitatory effect of cholecystokinin-unsulphated octapeptide (CCK-8 us) and caerulein (CER) on memory motivated affectively was investigated in male rats. CCK-8 us and CER were given subcutaneously at the doses of 10 microg kg(-1)and 0.5 microg kg(-1), respectively, immediately after a single learning trial in a passive avoidance situation, after bilateral 6-OHDA lesions to the dentate gyrus of the hippocampus. In order to protect noradrenergic neurones against destruction by neurotoxin, 30 min before surgery rats were pre-treated intraperitoneally with 25 mg kg(-1)of desmethylimipramine, an inhibitor of noradrenaline uptake. Bilateral 6-OHDA lesions to the hippocampus significantly attenuate the facilitatory effect of CCK-8 us and CER on retention of passive avoidance behaviour evaluated 24 h after the learning trial. Neither, destruction of dopaminergic endings in the hippocampus, nor application of CCK-8 us and CER changed the spontaneous psychomotor activity of rats estimated in an 'open field' test. These results may indicate that the facilitatory effect of CCK-8 us and CER on memory motivated affectively is, in part, mediated by dopaminergic projection from the ventral tegmental area to the dentate gyrus of the hippocampus. 2000 Academic Press@p$hr Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675288     DOI: 10.1006/phrs.1999.0591

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  3 in total

1.  Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6-hydroxydopamine.

Authors:  Napatr Sriraksa; Jintanaporn Wattanathorn; Supaporn Muchimapura; Somsak Tiamkao; Kamoltip Brown; Kowit Chaisiwamongkol
Journal:  Evid Based Complement Alternat Med       Date:  2011-07-18       Impact factor: 2.629

2.  A current review of cypermethrin-induced neurotoxicity and nigrostriatal dopaminergic neurodegeneration.

Authors:  Anand Kumar Singh; Manindra Nath Tiwari; Om Prakash; Mahendra Pratap Singh
Journal:  Curr Neuropharmacol       Date:  2012-03       Impact factor: 7.363

3.  Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson's disease.

Authors:  Galba Jean Beppe; Alain Bertrand Dongmo; Harquin Simplice Foyet; Nolé Tsabang; Zenovia Olteanu; Oana Cioanca; Monica Hancianu; Théophile Dimo; Lucian Hritcu
Journal:  BMC Complement Altern Med       Date:  2014-04-30       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.